Nabhan C, et al. Leuk. Lymphoma (2004) cited as Ref 551 in DOI: 10.1038/s41392-020-0110-5 (Q9814)

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Nabhan C, et al. Leuk. Lymphoma (2004) cited as Ref 551 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Nabhan C
    0 references
    0 references
    2004
    0 references
    Leuk. Lymphoma
    0 references
    45
    0 references
    A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL) (English)
    0 references
    2269-2273
    0 references